Developments in Post-marketing Comparative Effectiveness Research
- 6 June 2007
- journal article
- review article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 82 (2) , 143-156
- https://doi.org/10.1038/sj.clpt.6100249
Abstract
Physicians and insurers need to weigh the effectiveness of new drugs against existing therapeutics in routine care to make decisions about treatment and formularies. Because Food and Drug Administrat...Keywords
This publication has 84 references indexed in Scilit:
- Increasing Levels of Restriction in Pharmacoepidemiologic Database Studies of Elderly and Comparison With Randomized Trial ResultsMedical Care, 2007
- Reference drug programs: Effectiveness and policy implicationsHealth Policy, 2007
- Performance of Propensity Score Calibration--A Simulation StudyAmerican Journal of Epidemiology, 2007
- Understanding secondary databases: a commentary on “Sources of bias for health state characteristics in secondary databases”Journal of Clinical Epidemiology, 2007
- Availability of comparative trials for the assessment of new medicines in the European Union at the moment of market authorizationBritish Journal of Clinical Pharmacology, 2006
- Evaluating Short-Term Drug Effects Using a Physician-Specific Prescribing Preference as an Instrumental VariableEpidemiology, 2006
- Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeuticsPharmacoepidemiology and Drug Safety, 2006
- A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methodsJournal of Clinical Epidemiology, 2005
- Combination of direct and indirect evidence in mixed treatment comparisonsStatistics in Medicine, 2004
- The central role of the propensity score in observational studies for causal effectsBiometrika, 1983